Pretraživanje
Prikaz rezultata 11-15 od 15
Globin genes induction by nitric oxide of stromal cell origin
(Amer Soc Hematology, Washington, 2007)
Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells
(Amer Soc Hematology, Washington, 2008)
Hydroxyurea, a drug widely used for treating myeloproliferative diseases, has also been approved for the treatment of sickle cell disease by raising fetal hemoglobin (HbF). We have shown that nitric oxide (NO) and the ...
Serologic rebounds after one-year-long treatment for congenital toxoplasmosis
(Lippincott Williams & Wilkins, Philadelphia, 2000)
Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells
(Amer Soc Hematology, Washington, 2006)
Hydroxyurea is a cell-cycle-specific drug that has been used to treat myeloproliferative diseases and sickle cell anemia. We have recently shown that hydroxyurea, like nitric oxide (NO)-donor compounds, increased cGMP ...
Concentrations of IL-17 and autoantibodies in sera of patients with primary Sjogren's syndrome
(BMJ Publishing Group, London, 2007)